Tag: Andrew Percy

  • Andrew Percy – 2015 Parliamentary Question to the Department of Health

    Andrew Percy – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Percy on 2015-11-16.

    To ask the Secretary of State for Health, what assessment his Department has made of (a) the prevalence of child obesity and (b) whether there is a correlation between child obesity and deprivation; and what steps his Department is taking to address that issue.

    Jane Ellison

    We know obesity rates in children are far too high and children in lower income groups are more likely to be obese than the rest of the population, but it is an issue across all groups.

    Tackling obesity, particularly in children, is one of our major priorities. Progress has been made in recent years, but we know we have much further to go. We will announce our plans for tackling childhood obesity in the new year.

  • Andrew Percy – 2015 Parliamentary Question to the Department of Health

    Andrew Percy – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Percy on 2015-12-15.

    To ask the Secretary of State for Health, what discussions his Department has had with clinical commissioning groups on the implementation of recommendations contained in NHS England’s Nutrition and Hydration Commissioning Guidance.

    Jane Ellison

    Several clinical commissioning groups (CCGs) worked with NHS England to develop the guidance (Stafford, Leicesterand Rutland, Gateshead and Salford) and discussions continue with them about the ongoing implementation of the guidance.

    NHS England’s patient experience team has had discussions with Sutton CCG about implementation of the guidance as part of the Care Home Vanguard programme there.

    The five CCGs which make up North Central London Strategic Collaborative Commissioning Group are proposing to have one CQUIN to ensure they are ‘commissioning excellent nutrition and hydration’ services. This will be used for all nine acute providers that cover Barnet, Camden, Islington, Haringey and Enfield. They are going to share their proposed outcome measures as soon as they have been agreed.

  • Andrew Percy – 2016 Parliamentary Question to the Ministry of Justice

    Andrew Percy – 2016 Parliamentary Question to the Ministry of Justice

    The below Parliamentary question was asked by Andrew Percy on 2016-01-14.

    To ask the Secretary of State for Justice, how many defibrillators are provided in each building his Department manages.

    Mike Penning

    The information requested is not held centrally.

  • Andrew Percy – 2016 Parliamentary Question to the Department for Energy and Climate Change

    Andrew Percy – 2016 Parliamentary Question to the Department for Energy and Climate Change

    The below Parliamentary question was asked by Andrew Percy on 2016-01-14.

    To ask the Secretary of State for Energy and Climate Change, how many defibrillators are provided in each building her Department manages.

    Andrea Leadsom

    The number of defibrillators held in buildings managed by the Department is as follows:

    Building

    No. of defibrillators

    3 Whitehall Place, London, SW1A 2AW

    1

    55 Whitehall, London, SW1A 2EW

    1

    Atholl House, 86-88 Guild Street, Aberdeen, AB11 6AR

    1

  • Andrew Percy – 2016 Parliamentary Question to the Ministry of Justice

    Andrew Percy – 2016 Parliamentary Question to the Ministry of Justice

    The below Parliamentary question was asked by Andrew Percy on 2016-02-09.

    To ask the Secretary of State for Justice, what steps he is taking to give greater support to people with mental health vulnerabilities who come into contact with the criminal justice system.

    Andrew Selous

    Liaison and Diversion services place clinical staff at police stations and courts to assess and identify offenders for a range of health problems, including mental health, and then make referrals to treatment and support services. Information about their health needs can be shared so that court proceedings, decisions and sentences can be tailored to meet needs. Where appropriate offenders can be diverted towards appropriate interventions.

    In April 2014, services were launched in 10 trial areas, and extended in April 2015 to a further 15 areas. This brings current coverage to over half of England. We are also exploring how problem-solving courts can support people with complex needs. A working group has been established in partnership with the judiciary which will make recommendations in due course.

  • Andrew Percy – 2016 Parliamentary Question to the Department of Health

    Andrew Percy – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Percy on 2016-02-24.

    To ask the Secretary of State for Health, what representations he has received on the proposals contained in the report, Surrogacy in the UK: Myth Busting and Reform, published in November 2015.

    Jane Ellison

    A search of the Department’s central correspondence system shows that the Department received 22 representations that made direct or indirect reference to the report `Surrogacy in the UK: Myth Busting and Reform’ since it was published in November 2015.

    The Government has no current plans to change the legislation in respect of surrogacy arrangements.

  • Andrew Percy – 2016 Parliamentary Question to the Department for Communities and Local Government

    Andrew Percy – 2016 Parliamentary Question to the Department for Communities and Local Government

    The below Parliamentary question was asked by Andrew Percy on 2016-03-07.

    To ask the Secretary of State for Communities and Local Government, what steps he is taking to ensure that there are safeguards against flooding for the construction of new houses in potential flood-risk areas.

    Brandon Lewis

    There are strict tests in the National Planning Policy Framework to protect people and property from flooding which all local planning authorities are expected to follow, underpinned by our planning practice guidance. The Framework is clear that local planning authorities should avoid inappropriate development in areas at risk of flooding by directing development away from areas at highest risk. Where development is necessary in a flood risk area, it must be demonstrated that it will be safe, without increasing flood risk elsewhere, and be appropriately flood resilient and resistant. Mitigation measures, such as land raising, raised building thresholds and improved flood management infrastructure, to make development acceptable in flood risk areas can be made a requirement of any planning consent.

    We are clear that where the strict tests on flood risk set out in national planning policy are not met, new development should not be allowed.

  • Andrew Percy – 2016 Parliamentary Question to the Department of Health

    Andrew Percy – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Percy on 2016-03-24.

    To ask the Secretary of State for Health, how much the NHS spent on treating people with inflammatory bowel disease in (a) the last 12 months and (b) each of the last five financial years.

    Jane Ellison

    The information is not available in the format requested.

    Such information as is available on the cost to the National Health Service of treating inflammatory bowel disease is from reference costs, which are the average unit cost to NHS hospital trusts of providing defined services to patients in a given financial year. Reference costs for acute care are collected by Healthcare Resource Group (HRG), a secondary classification system which groups similar treatments that use similar resources. Reference costs are published annually, most recently for 2014-15.

    The following table reflects the costs of treating patients who are admitted to hospital and does not include the treatment of inflammatory bowel disease in outpatient or other settings outside of hospital. The costs are not comparable between years because of changes to the HRG design and to the underlying primary classification system for diseases.

    Estimated total costs (£millions) to NHS hospitals of treating inflammatory bowel disease, 2010-11 to 2014-15

    2010-11

    2011-12

    2012-13

    2013-14

    2014-15

    Inflammatory bowel disease

    207.3

    147.1

    73.0

    78.8

    82.9

    Paediatric inflammatory bowel disease

    12.1

    8.4

    9.7

    10.6

    10.9

    Total

    219.4

    155.5

    82.6

    89.5

    93.8

    Source: Reference costs, Department of Health

    Notes:

    1. For each HRG or other currency in the reference cost collection, NHS hospital trusts submit a unit cost and amount of activity undertaken.
    2. Costs are not comparable between years:
      1. changes to the HRG design in 2011-12 resulted in the removal of HRGs specific to procedures for inflammatory bowel disease. These costs are included in other HRGs and are no longer separately identifiable.
      2. revised clinical coding guidance introduced in 2012-13 with the International Classification of Diseases 10th revision (ICD-10), fourth edition, resulted in the transfer of significant activity (and therefore costs) associated with infectious gastroenteritis and colitis to other HRGs.
    3. The following HRGs are included in the table:

    2010-11

    FZ37F Inflammatory Bowel Disease with length of stay 1 day or less

    FZ37G Inflammatory Bowel Disease with length of stay 2 days or more with Major Complications and Comorbidities (CC) with Interventions

    FZ37H Inflammatory Bowel Disease with length of stay 2 days or more with Major CC without Interventions

    FZ37I Inflammatory Bowel Disease with length of stay 2 days or more without Major CC with Interventions

    FZ37J Inflammatory Bowel Disease with length of stay 2 days or more without Major CC without Interventions

    FZ14Z Complex Procedures for Inflammatory Bowel Disease

    FZ15Z Major Procedures for Inflammatory Bowel Disease

    FZ28A Endoscopic or Intermediate Procedures for Inflammatory Bowel Disease 19 years and over with CC

    FZ28B Endoscopic or Intermediate Procedures for Inflammatory Bowel Disease 19 years and over without CC

    FZ28C Endoscopic or Intermediate Procedures for Inflammatory Bowel Disease 18 years and under

    PA27Z Inflammatory Bowel Disease

    2011-12

    FZ37F Inflammatory Bowel Disease with length of stay 1 day or less

    FZ37G Inflammatory Bowel Disease with length of stay 2 days or more with Major CC with Interventions

    FZ37H Inflammatory Bowel Disease with length of stay 2 days or more with Major CC without Interventions

    FZ37I Inflammatory Bowel Disease with length of stay 2 days or more without Major CC with Interventions

    FZ37J Inflammatory Bowel Disease with length of stay 2 days or more without Major CC without Interventions

    PA27Z Inflammatory Bowel Disease

    2012-13

    FZ37K Inflammatory Bowel Disease with Multiple Interventions, with CC Score 3+

    FZ37L Inflammatory Bowel Disease with Multiple Interventions, with CC Score 0-2

    FZ37M Inflammatory Bowel Disease with Single Intervention, with CC Score 4+

    FZ37N Inflammatory Bowel Disease with Single Intervention, with CC Score 0-3

    FZ37P Inflammatory Bowel Disease without Interventions, with CC Score 5+

    FZ37Q Inflammatory Bowel Disease without Interventions, with CC Score 3-4

    FZ37R Inflammatory Bowel Disease without Interventions, with CC Score 1-2

    FZ37S Inflammatory Bowel Disease without Interventions, with CC Score 0

    PA27Z Inflammatory Bowel Disease

    2013-14 and 2014-15

    FZ37K Inflammatory Bowel Disease with Multiple Interventions, with CC Score 3+

    FZ37L Inflammatory Bowel Disease with Multiple Interventions, with CC Score 0-2

    FZ37M Inflammatory Bowel Disease with Single Intervention, with CC Score 4+

    FZ37N Inflammatory Bowel Disease with Single Intervention, with CC Score 0-3

    FZ37P Inflammatory Bowel Disease without Interventions, with CC Score 5+

    FZ37Q Inflammatory Bowel Disease without Interventions, with CC Score 3-4

    FZ37R Inflammatory Bowel Disease without Interventions, with CC Score 1-2

    FZ37S Inflammatory Bowel Disease without Interventions, with CC Score 0

    PF27A Paediatric Inflammatory Bowel Disease with CC Score 1+

    PF27B Paediatric Inflammatory Bowel Disease with CC Score 0

  • Andrew Percy – 2016 Parliamentary Question to the Department for Communities and Local Government

    Andrew Percy – 2016 Parliamentary Question to the Department for Communities and Local Government

    The below Parliamentary question was asked by Andrew Percy on 2016-04-25.

    To ask the Secretary of State for Communities and Local Government, what assessment he has made of how much local authorities will be able to collect through business rates under the Government’s devolution proposals in (a) East Yorkshire, (b) North Lincolnshire and (c) elsewhere.

    Mr Marcus Jones

    The Government intends to move to 100% business rates retention in England by the end of this Parliament. We have confirmed that as part of the new system there will continue to be redistribution of local tax revenue between authorities and protections in place for authorities that see their business rates income fall significantly. Over the coming months we will be working with local government on the details of the scheme.

    Ahead of final decisions, it is too early to assess what the impact will be on individual areas or authorities. However, based on their own estimates, East Riding of Yorkshire Council and North Lincolnshire Council expect to collect £106.9 million and £89.2 million in business rates respectively in 2016-17.

  • Andrew Percy – 2016 Parliamentary Question to the Department of Health

    Andrew Percy – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Percy on 2016-05-23.

    To ask the Secretary of State for Health, with reference to the report of Surrogacy UK, Surrogacy in the UK: Myth busting and reform, published on 28 April 2016, if he will take steps to publish a legal pathway document for intended parents and surrogates.

    Jane Ellison

    Surrogacy is a complex issue, the legislation about which has not been significantly addressed by respective administrations since the Surrogacy Arrangements Act was introduced in 1985. The Government recognises the arguments for the need for a review, and we have therefore asked the Law Commission, as part of the consultation on its 13th work programme this summer, to consider including a project on surrogacy.

    The Department has not issued guidance about surrogacy to professional groups or the Children and Family Court Advisory and Support Service (CAFCASS). The Government recognises surrogacy as an important option for some people wishing to start a family and is currently considering how best to clarify the current legal arrangements for intended parents, surrogates and their families. The CAFCASS campaign to increase awareness of Parental Orders is ongoing and targeted at health workers, local authority registration staff and surrogacy agencies. It will be evaluated in full upon completion in autumn 2016; in-campaign monitoring indicates its messaging is reaching the target audience.